SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-032781
Filing Date
2021-06-14
Accepted
2021-06-14 16:17:43
Documents
5
Period of Report
2021-06-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cccc-8k_20210614.htm 8-K 39677
2 EX-99.1 cccc-ex991_8.htm EX-99.1 14369
3 EX-99.2 cccc-ex992_23.htm EX-99.2 11976
4 GRAPHIC gj31hmqnbdq0000001.jpg GRAPHIC 7489
5 GRAPHIC g24xvdiw4dkr000001.jpg GRAPHIC 7489
  Complete submission text file 0001564590-21-032781.txt   88085
Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39567 | Film No.: 211014803
SIC: 2836 Biological Products, (No Diagnostic Substances)